- Home
- BDTX vs JRVR Comparison
BDTX vs JRVR Comparison
Compare BDTX & JRVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BDTX | JRVR |
|---|---|---|
| Founded | 2014 | 2002 |
| Country | United States | United States |
| Employees | N/A | 578 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 116.8M | 282.7M |
| IPO Year | 2020 | 2014 |
Fundamental Metrics
Financial Performance| Metric | BDTX | JRVR |
|---|---|---|
| Price | $2.03 | $6.15 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 6 | 3 |
| Target Price | ★ $10.20 | $7.33 |
| AVG Volume (30 Days) | ★ 571.5K | 260.9K |
| Earning Date | 03-16-2026 | 03-02-2026 |
| Dividend Yield | N/A | ★ 0.64% |
| EPS Growth | ★ 130.71 | 125.82 |
| EPS | 0.39 | ★ 0.79 |
| Revenue | N/A | ★ $687,614,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $1.61 |
| P/E Ratio | ★ $5.46 | $7.96 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.20 | $3.85 |
| 52 Week High | $4.94 | $7.20 |
Technical Indicators
Market Signals| Indicator | BDTX | JRVR |
|---|---|---|
| Relative Strength Index (RSI) | 39.11 | 40.57 |
| Support Level | $1.93 | $6.07 |
| Resistance Level | $2.30 | $6.88 |
| Average True Range (ATR) | 0.11 | 0.19 |
| MACD | -0.00 | -0.02 |
| Stochastic Oscillator | 1.82 | 30.56 |
Price Performance
Historical ComparisonAbout BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.
About JRVR James River Group Holdings Ltd.
James River Group Holdings Inc is a holding company that owns and operates a group of specialty insurance companies focused on underwriting small and middle market casualty risks within the U.S. excess and surplus (E&S) lines market. The Company operates in two specialty property-casualty insurance segments: Excess and Surplus Lines and Specialty Admitted Insurance.